U.S. Public M&A Activity

July 14, 2008

Target: APP Pharmaceuticals Inc (2834)Acquiror: Fresenius SE (3845)Illinois

Mnfr, whl, dvlp pharm prod

Goldman Sachs; LazardForeign

Mnfr medical equip

Deutsche Bank Deal InformationValue:

Price:

Type:

Announced:

Sales:

Cash Flow:5,628.0

23.00

Merger

07/07/08

583.3

32.4 |

|

|

|

|

| Earnings:

EPS Growth (5Yr):

Total Assets:

L-T Debt:

Deprec/Amort:

Enterprise Value:211.6

1,087.1

990.6

35.7

4,654.9US - Fresenius SE definitively agreed to acquire all the outstanding common stock of APP Pharmaceuticals Inc, a manufacturer, wholesaler and developer of pharmaceutical products, for $23 in cash per share, or a total value of $5.628 bil,…

The full article is available to Mergers Unleashed subscribers only

Are you an existing M&A Magazine subscriber and/or ACG member?

 Yes     No

Already a print subscriber? As a print subscriber, you are entitled to online access. Please click here to activate your account.